Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...

The near-term trigger for the stock is its plan to acquire Amplitude Surgical. Amplitude had a 5 per cent year-on-year (Y-o-Y ...

Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging ...

Zynext Ventures, the venture capital arm of Zydus Lifesciences, has invested in Illexcor Therapeutics to support the ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for €257 million (Rs 2,500 crore).

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

The purchase price is €6.25 per share of equity, putting the transaction value at €256.8 million for the 85.6% stake.

Pennington: Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has announced its investment in Illexcor ...

Fueling Growth: Company Secures Major Solar Orders and Unlocks Funds for 1 GW... The stock gave multibagger returns of over 200 per cent from its 52-week low of Rs 4.41 per share. In order to achieve ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

Stocks like Tata Steel, NHPC, NTPC Green Energy, Firstsource Solutions, Coromandel International, SP Apparels, Zydus ...